Cargando…
Characterizing the secretome of licensed hiPSC-derived MSCs
Although mesenchymal stromal cells (MSCs) from primary tissues have been successfully applied in the clinic, their expansion capabilities are limited and results are variable. MSCs derived from human-induced pluripotent stem cells (hiMSCs) are expected to overcome these limitations and serve as a re...
Autores principales: | Ramos, Yolande F. M., Tertel, Tobias, Shaw, Georgina, Staubach, Simon, de Almeida, Rodrigo Coutinho, Suchiman, Eka, Kuipers, Thomas B., Mei, Hailiang, Barry, Frank, Murphy, Mary, Giebel, Bernd, Meulenbelt, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438242/ https://www.ncbi.nlm.nih.gov/pubmed/36056373 http://dx.doi.org/10.1186/s13287-022-03117-2 |
Ejemplares similares
-
hiPSC‐derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine
por: Sabapathy, Vikram, et al.
Publicado: (2016) -
Repeated intravenous administration of hiPSC-MSCs enhance the efficacy of cell-based therapy in tissue regeneration
por: Sun, Si-Jia, et al.
Publicado: (2022) -
hiPSC-Derived Cells as Models for Drug Discovery
por: Ofir, Rivka
Publicado: (2021) -
A mathematical model of hiPSC cardiomyocytes electromechanics
por: Forouzandehmehr, Mohamadamin, et al.
Publicado: (2021) -
Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR Injury via Inhibition of Hepatic Senescence
por: Qi, Xiang, et al.
Publicado: (2018)